Ropivacaine is an aminoamide local anesthetic drug marketed by AstraZeneca under the trade name Naropin. It exists as a racemate of its S- and R-enantiomers, although the marketed form is supplied only as the purified S-enantiomer.
Ropivacaine is indicated in adult patients for the induction of regional or local anesthesia for surgery or acute pain management.
Asklepieion Hospital of Voula, Athens, Greece
First affiliated hospital of third military medical university, Chongqing, Chongqing, China
II Department of Anesthesia and Intensive Care, Medical University of Lublin, Lublin, Poland
Paraskevi K Matsota, Athens, Other, Greece
The Ottawa Hospital, Ottawa, Ontario, Canada
Columbia University Irving Medical Center, New York, New York, United States
Duke University Hospital, Durham, North Carolina, United States
University Hospital of North Norway, Tromsø, Troms, Norway
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.